Merz Therapeutics

Vensica is focused on developing an innovative ultrasound-based drug delivery system aimed at improving the treatment of urinary bladder conditions, particularly bladder cancer and overactive bladder (OAB). Traditional treatment methods involve instilling medication directly into the bladder via a catheter, which can be inefficient and painful. Vensica's approach utilizes ultrasound to enhance drug uptake and penetration into the bladder wall, facilitating a quick and pain-free procedure for patients. This method aims to increase the effectiveness of treatments and reduce the high recurrence rates associated with bladder cancer, which can be as high as 70%. By leveraging ultrasound technology, Vensica seeks to provide safer and more effective treatment options for individuals suffering from these conditions.

Vensica is focused on developing an innovative ultrasound-based drug delivery system aimed at improving the treatment of urinary bladder conditions, particularly bladder cancer and overactive bladder (OAB). Traditional treatment methods involve instilling medication directly into the bladder via a catheter, which can be inefficient and painful. Vensica's approach utilizes ultrasound to enhance drug uptake and penetration into the bladder wall, facilitating a quick and pain-free procedure for patients. This method aims to increase the effectiveness of treatments and reduce the high recurrence rates associated with bladder cancer, which can be as high as 70%. By leveraging ultrasound technology, Vensica seeks to provide safer and more effective treatment options for individuals suffering from these conditions.